Human African trypanosomiasis of the CNS: current issues and challenges

AUTOR(ES)

Kennedy, Peter G.E.

FONTE

American Society for Clinical Investigation

RESUMO

Human African trypanosomiasis (HAT), also known as sleeping sickness, is a major cause of mortality and morbidity in sub-Saharan Africa. Current therapy with melarsoprol for CNS HAT has unacceptable side-effects with an overall mortality of 5%. This review discusses the issues of diagnosis and staging of CNS disease, its neuropathogenesis, and the possibility of new therapies for treating late-stage disease.

Documentos Relacionados

• Options for Field Diagnosis of Human African Trypanosomiasis
• Pancarditis affecting the conducting system and all valves in human African trypanosomiasis.
• Immunology and immunopathology of African trypanosomiasis
• Suppression of malignancy in human cancer cells: issues and challenges.
• Fexinidazole and Human African Trypanosomiasis: good news for this important neglected tropical disease